GNOTOBIOTIOCHE UNTERSUCHUNGEN-EIN MIKROBIOLOGISCHER BEITRAG ZUR DEKONTAMINATION VON KNOCHENMARKTRANSPLANTIERTEN LEUKAEMIEPATIENTEN = RECHERCHES GNOTOBIOTIQUES. UNE CONTRIBUTION MICROBIOLOGIQUE A LA DECONTAMINATION DE MALADES LEUCEMIQUES AYANT SUBI UNE TRANSPLANTATION DE MOELLE OSSEUSEHARALAMBIE E; LINZENMEIER G; NOWROUSIAN M et al.1980; IMMUN. INFEKT.; ISSN 0340-1162; DEU; DA. 1980; VOL. 8; NO 3; PP. 89-95; ABS. ENG; BIBL. 31 REF.Article

An efficient procedure to isolate fungal genes from an indexed cosmid libraryPÖGGELER, S; NOWROUSIAN, M; JACOBSEN, S et al.Journal of microbiological methods. 1997, Vol 29, Num 1, pp 49-61, issn 0167-7012Article

Reversed-phase high-performance liquid chromatographic determination of anaxirone in biological specimensSCHILCHER, R. B; YOUNG, J. D; NOWROUSIAN, M. R et al.Journal of chromatography. 1986, Vol 378, Num 1, pp 248-253, issn 0021-9673Article

Bolus vincristine and epirubicin with cyclophosphamide and dexamethasone (VECD) as induction and salvage treatment in multiple myelomaFOSSA, A; MUER, M; KASPER, C et al.Leukemia. 1998, Vol 12, Num 3, pp 422-426, issn 0887-6924Article

Reversed-phase high-performance liquid chromatographic determination of anaxirone in biological specimensSCHILCHER, R. B; YOUNG, J. D; NOWROUSIAN, M. R et al.Journal of chromatography. 1986, Vol 378, Num 1, pp 248-253, issn 0021-9673Article

Epoetin beta (neorecormon®) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy : a meta-analysisBOOGAERTS, M; OBERHOFF, C; TEN BOKKEL HUININK, W et al.Anticancer research. 2006, Vol 26, Num 1B, pp 479-484, issn 0250-7005, 6 p.Article

Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphomaFOSSA, A; SANTORO, A; HIDDEMANN, W et al.Journal of clinical oncology. 1999, Vol 17, Num 12, pp 3786-3792, issn 0732-183XArticle

Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysisMÜLLER, M. R; LENNARTZ, K; NOWROUSIAN, M. R et al.Cytometry (New York, N.Y.). 1994, Vol 15, Num 1, pp 64-72, issn 0196-4763Article

Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantationLINDEMANN, M; SCHUETT, P; MORITZ, T et al.Leukemia. 2005, Vol 19, Num 3, pp 490-492, issn 0887-6924, 3 p.Article

Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell linesSIEBERT, R; WILLERS, C. P; FOSSA, A et al.Leukemia research. 1996, Vol 20, Num 2, pp 197-200, issn 0145-2126Article

BCR rearrangement without juxtaposition of ABL in pre-T acute lymphoblastic leukaemiaFOSSA, A; SIEBERT, R; KASPER, C et al.British journal of haematology. 1996, Vol 93, Num 2, pp 403-405, issn 0007-1048Article

How to improve therapy for adult myeloid leukemia : studies of tha AML cooperative group in the Federal republic of GermanyBUÊCHNER, T; HIDDEMANN, W; MASCHMEYER, G et al.Journal of cancer research and clinical oncology. 1990, Vol 116, Num 1, pp 97-99, issn 0171-5216, 3 p.Conference Paper

Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphomaNOWROUSIAN, M. R; MEIER, C. R; SCHOETENSACK, B et al.Acta oncologica (Stockholm). 1989, Vol 28, Num 4, pp 495-500, issn 0284-186X, 6 p.Article

Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patientsNOWROUSIAN, M. R; WASCHKE, S; BOJKO, P et al.Annals of oncology. 2003, Vol 14, pp i29-i36, issn 0923-7534, SUP1Conference Paper

Nitrousoureas: modes of action and perspectives in the use of hormone receptor affine carrier moleculesEISENBRAND, G; BERGER, M. R; ZELEZNY, O et al.Acta oncologica (Stockholm). 1989, Vol 28, Num 2, pp 203-211, issn 0284-186X, 9 p.Conference Paper

Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell linesSIEBERT, R; WILLERS, C. P; SCHRAMM, A et al.British journal of haematology. 1995, Vol 91, Num 2, pp 350-354, issn 0007-1048Article

Longterm effects of prolonged maintenance and of very early intensification chemotherapy in AML : data from AMLCGBÜCHNER, T; HIDDEMANN, W; SAUERLAND, C et al.Leukemia. 1992, Vol 6, pp 68-71, issn 0887-6924, SUP2Conference Paper

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors : A randomized, controlled studyOBERHOFF, C; NERI, B; HERRMANN, R et al.Annals of oncology. 1998, Vol 9, Num 3, pp 255-260, issn 0923-7534Article

Adult AML : the role of chemotherapy intensity and duration. Two studies of the AML cooperative groupBÜCHNER, T; HIDDEMANN, W; SEIBT-JUNG, H et al.Haematology and blood transfusion. 1990, Vol 33, pp 261-266, issn 0171-7111Article